The Chicago Entrepreneur

Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program

Sesame is offering compounded semaglutide — the active ingredient in Wegovy and Ozempic — to help users access obesity and diabetes treatments amid shortages.

Previous post Target will report earnings before the bell. Here’s what to expect
Next post Hedge funds’ early exit from Magnificent Seven stocks helped them navigate summer slump